Are you Dr. Schilsky?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 88 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
180 Harvester Dr
Ste 110
Burr Ridge, IL 60527Phone+1 773-834-4064
Summary
- Dr. Richard Schilsky, MD is an oncologist in Burr Ridge, Illinois. He is currently licensed to practice medicine in Illinois and Missouri. He is a Professor of Medicine at University of Chicago Medicine.
Education & Training
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1975 - 1977
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1975
Certifications & Licensure
IL State Medical License 1984 - 2023
MO State Medical License Active through 2013- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2012
- Super Doctor SuperDoctors.com
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Start of enrollment: 2008 Apr 01
- Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement Start of enrollment: 2009 Mar 01
Publications & Presentations
PubMed
- 31 citationsThe International Collaboration for Cancer Classification and ResearchIan A. Cree, Iciar Indave, Jiri Zavadil, James McKay, Magali Olivier
International Journal of Cancer. 2021-02-01 - 909 citationsAmerican Society of Clinical Oncology Provisional Clinical Opinion: Testing for KRAS Gene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Respons...Carmen J. Allegra, J. Milburn Jessup, Mark R. Somerfield, Stanley R. Hamilton, Elizabeth H. Hammond
Journal of Clinical Oncology. 2009-04-20 - 608 citationsEffect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: ...Alan P. Venook, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Briant Fruth
JAMA. 2017-06-20
Press Mentions
KCA Brings Early-Career Clinicians Together for New Mentorship ProgramNovember 14th, 2024- ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
- The Evolution of NCI’s National Clinical Trials NetworkNovember 1st, 2021
- Join now to see all
Grant Support
- Cancer And Leukemia Group BNational Cancer Institute1995–2010
- Cancer And Leukemia Group B Human Specimen RepositoriesNational Cancer Institute2005–2009
- Cancer And Leukemia Group BNational Cancer Institute1995–2009
- Calgb - Foreign AccrualNational Cancer Institute2005
- Calgb Foreign AccrualNational Cancer Institute2003–2004
- Calgb Studies Of Breast Cancer In The ElderlyNational Cancer Institute2000–2004
- Cancer And Leukemia Group B CCOP Research BaseNational Cancer Institute1999–2003
- Phase I Study Of O-6 Benzylguanine And Carmustine In Advanced CancerNational Center For Research Resources1996–2002
- Core--Protocol Specific Research SupportNational Cancer Institute1996–2001
- Core--Developmental FundsNational Cancer Institute1996–2001
- Uccrc--Cancer Center Support GrantNational Cancer Institute1996–1998
- Phase I Trial Of 5 Ethynyluracil PLUS 5 Fluorouracil For Solid TumorsNational Center For Research Resources1997
- Cancer And LeukemiaNational Cancer Institute1997
- Cancer Center Support GrantNational Cancer Institute1992–1996
- Phase I Trial Of 5-Ethynyluracil PLUS 5-Fluorouracil In Patients With TumorsNational Center For Research Resources1995
- Cancer And Leukemia Group BNational Cancer Institute1993–1994
- Univ Of Chicago CA RES Ctr: Cancer Center Support GrantNational Cancer Institute1993
- Phase I 5-Flurouracil &Leucovorin In Patients With Renal Or Hepatic DysfunctionNational Center For Research Resources1992–1993
- Univ Of Chgo CA RES Ctr--Cancer Center Support GrantNational Cancer Institute1992
- Chemotherapy Committee--Cancer And Leukemia Group BNational Cancer Institute1990–1992
- Univ Of Chgo CA RES Ctr: Cancer Center Support GrantNational Cancer Institute1991
- Clinical &Pharmacological Studies Of IP ChemotherapyNational Center For Research Resources1990–1991
- Cellular Pharmacology Of The Stereoisomers Of LeucovorinNational Cancer Institute1989–1991
- Cellular Pharmacology Of The Stereoisomers Of LeucovorinNational Cancer Institute1989
- Clinical Pharmacologic Studies Of I.P. Chemothx For I.P. CancerNational Center For Research Resources1988–1989
- Intraperitoneal Chemotherapy For Advanced Intraperitoneal &Intrahepatic CancerNational Center For Research Resources1987
- Phase I Study Of Thymidine And Cis-Platin In Patients With Advanced CancerNational Center For Research Resources1985–1986
Professional Memberships
- Fellow
